Active repression of cell fate plasticity by PROX1 safeguards hepatocyte identity and prevents liver tumourigenesis
Bryce Lim,Aryan Kamal,Borja Gomez Ramos,Juan Adrian Segarra,Ignacio Ibarra,Lennart Dignas,Tim Kindinger,Kai Volz,Mohammad Rahbari,Nuh Rahbari,Eric Poisel,Kanela Kafetzopoulou,Lio Bose,Marco Breinig,Danijela Heide,Suchira Gallage,Jose Barragan Avila,Hendrik Wiethoff,Ivan Berest,Sarah Schnabellehner,Martin Schneider,Jonas Becker,Dominic Helm,Dirk Grimm,Taija Makinen,Darjus Tschaharganeh,Mathias Heikenwalder,Judith B Zaugg,Moritz Mall
DOI: https://doi.org/10.1101/2024.09.10.612045
2024-09-13
Abstract:Cell fate plasticity enables development, yet unlocked plasticity is a cancer hallmark. Regulating cell identity requires gene activation and repression. While master regulators induce lineage-specific genes to restrict plasticity, it remains unclear whether unwanted plasticity is actively suppressed by lineage-specific repressors. Here, we computationally predict so-called safeguard repressors for 18 cell types that block phenotypic plasticity lifelong. We validated hepatocyte-specific candidates using reprogramming, revealing that Prospero homeobox protein 1 (PROX1) enhanced hepatocyte identity by direct repression of alternate fate master regulators. In mice, Prox1 was required for efficient hepatocyte regeneration after injury and acted as a tumour suppressor in multiple liver cancer models. In line with patient data, Prox1 depletion caused hepatocyte fate loss in vivo, and promoted transition of hepatocellular carcinoma to cholangiocarcinoma, conversely, overexpression promoted cholangiocarcinoma to hepatocellular carcinoma transdifferentiation. Our findings provide mechanistic evidence for PROX1 as a hepatocyte-specific safeguard and support a model where individual cell type-specific repressors actively suppress plasticity throughout life to safeguard lineage choice and prevent disease.
Cancer Biology